Low ERRC1 expression correlates with prolonged survival after cisplatin plus gemcitabine chemotherapy in non-small cell lung cancer

1. Lord, R.V.N.
2. Brabender, J.
3. Gandara, D.
4. Alberola, V.
5. Camps, C.
6. Domine, M.
7. Cardenal, F.
8. Sánchez, J.M.
9. Gumerlock, P.H.
10. Tarón, M.
11. Sánchez, J.J.
12. Danenberg, K.D.
13. Danenberg, P.V.
14. Rosell, R.